MetLife, Inc. (NYSE:MET) is garnering interest, being recognized as a top insurance stock by hedge funds.
LSV Asset Management's MET stake is valued at $152.88 million as
Barclays and
Wells Fargo adjust MET's price target. Multiple analysts have expressed anticipation over MET's prospects as various investors such as
F M Investments LLC,
DrW Securities LLC, and
Russell Investments Group Ltd grow their MET shares. However, others like the Bank of Nova Scotia and Westpac Banking Corp are reducing holdings.
David Herzog's departure from MET's board affected market performance with a 13% shares drop. MET's Q1 2025 results, Q4 earnings estimates, and launch of a digital platform for its 50M-member dental network are anticipated. MET also acquired
PineBridge Investments, partnered with
General Atlantic for the formation of Chariot Re, and nabbed the 2025
CIO 100 Award. Despite price target cuts by JPMorgan Chase and Barclays, MET remains a valuable investment with strong digital innovation and positive workplace rankings.
Metlife MET News Analytics from Thu, 03 Oct 2024 07:00:00 GMT to Sat, 12 Apr 2025 12:14:30 GMT -
Rating 6
- Innovation 5
- Information 8
- Rumor 3
